Association of an oral formulation of angiotensin-(1-7) with atenolol improves lipid metabolism in hypertensive rats

Peptides

Volumn 43, Issue , 2013, Pages 155-159

  Santos, Cynthia F F ^a   Santos, Sérgio H S ^a,b   Ferreira, Adaliene V M ^a   Botion, Leida M ^a   Santos, Robson A S ^a   Campagnole Santos, Maria Jose ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIMONTES   (Brazil)

Author keywords

Angiotensin (1 7); Atenolol; Dyslipidemia; Mas receptor; Renin angiotensin system; SHR

Indexed keywords

ATENOLOL; GLUCOSE; ISOPRENALINE;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FAT; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CONTROLLED STUDY; INSULIN SENSITIVITY; LIPID METABOLISM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN I; ANIMALS; ATENOLOL; HYPERTENSION; LIPID METABOLISM; MALE; PEPTIDE FRAGMENTS; RATS; RATS, INBRED SHR;

RATTUS;

EID: 84875917046     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2013.03.009     Document Type: Article

References (29)

1. P. Belfrage, and M. Vaughan Simple liquid-liquid partition system for isolation of labeled oleic acid from mixtures with glycerides J Lipid Res 10 1969 341 344
2. V. Bilman, L. Mares-Guia, A.P. Nadu, M. Bader, M.J. Campagnole-Santos, and R.A. Santos Decreased hepatic gluconeogenesis in transgenic rats with increased circulating angiotensin-(1-7) Peptides 37 2012 247 251
3. S.M. Caligiorne, A.Q. Silva, M.A. Fontes, J.R. Silva, O. Baltatu, and M. Bader Baroreflex control of heart rate and renal sympathetic nerve activity in rats with low brain angiotensinogen Neuropeptides 42 2008 159 168
4. J. Chen, D. Li, R. Schaefer, and J.L. Mehta Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan Atherosclerosis 184 2006 295 301
5. M. Davidson A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome Am J Cardiol 102 2008 19L 27L
6. V.A. Fonseca Effects of beta-blockers on glucose and lipid metabolism Curr Med Res Opin 26 2010 615 629
7. A. Green Adenosine receptor down-regulation and insulin resistance following prolonged incubation of adipocytes with an A1 adenosine receptor agonist J Biol Chem 262 1987 15702 15707
8. G.G. Guimaraes, S.H. Santos, M.L. Oliveira, E.P. Pimenta-Velloso, D.F. Motta, and A.S. Martins Exercise induces renin-angiotensin system unbalance and high collagen expression in the heart of Mas-deficient mice Peptides 38 2012 54 61
9. D. Hyson, J.C. Rutledge, and L. Berglund Postprandial lipemia and cardiovascular disease Curr Atheroscler Rep 5 2003 437 444
10. N. Iritani, E. Fukuda, Y. Nara, and Y. Yamori Lipid metabolism in spontaneously hypertensive rats (SHR) Atherosclerosis 28 1977 217 222
11. P.H. Jones Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering Am J Cardiol 102 2008 41L 47L
12. I. Lula, A.L. Denadai, J.M. Resende, F.B. de Sousa, G.F. de Lima, and D. Pilo-Veloso Study of angiotensin-(1-7) vasoactive peptide and its beta-cyclodextrin inclusion complexes: complete sequence-specific NMR assignments and structural studies Peptides 28 2007 2199 2210
13. E.G. Mario, S.H. Santos, A.V. Ferreira, M. Bader, R.A. Santos, and L.M. Botion Angiotensin-(1-7) Mas-receptor deficiency decreases peroxisome proliferator-activated receptor gamma expression in adipocytes Peptides 33 2012 174 177
14. Y. Mori, H. Nakagiri, H. Kondo, T. Murase, I. Tokimitsu, and N. Tajima Dietary diacylglycerol reduces postprandial hyperlipidemia and ameliorates glucose intolerance in Otsuka Long-Evans Tokushima Fatty (OLETF) rats Nutrition 21 2005 933 939
15. K. Nagata, and T. Hattori Cardioprotective mechanisms of lifestyle modifications and pharmacotherapies on cardiac remodeling and dysfunction in hypertensive heart disease: an overview Nagoya J Med Sci 73 2011 91 105
16. P. Nilsson-Ehle, and M.C. Schotz A stable, radioactive substrate emulsion for assay of lipoprotein lipase J Lipid Res 17 1976 536 541
17. A. Ribeiro-Oliveira Jr., A.I. Nogueira, R.M. Pereira, W.W. Boas, R.A. Dos Santos, and A.C. Simoes e Silva The renin-angiotensin system and diabetes: an update Vasc Health Risk Manage 4 2008 787 803
18. V. Ruiz-Gutierrez, C.M. Vazquez, and C. Santa-Maria Liver lipid composition and antioxidant enzyme activities of spontaneously hypertensive rats after ingestion of dietary fats (fish, olive and high-oleic sunflower oils) Biosci Rep 21 2001 271 285
19. R.A. Santos, A.J. Ferreira, S.V. Pinheiro, W.O. Sampaio, R. Touyz, and M.J. Campagnole-Santos Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs Expert Opin Investig Drugs 14 2005 1019 1031
20. S.H. Santos, J.F. Braga, E.G. Mario, L.C. Porto, G. Rodrigues-Machado Mda, and A. Murari Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7) Arterioscler Thromb Vasc Biol 30 2010 953 961
21. S.H. Santos, L.R. Fernandes, E.G. Mario, A.V. Ferreira, L.C. Porto, and J.I. Alvarez-Leite Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism Diabetes 57 2008 340 347
22. S.H. Santos, L.R. Fernandes, C.S. Pereira, A.L. Guimaraes, A.M. de Paula, and M.J. Campagnole-Santos Increased circulating angiotensin-(1-7) protects white adipose tissue against development of a proinflammatory state stimulated by a high-fat diet Regul Pept 178 2012 64 70
23. N. Serhan, C. Cabou, C. Verdier, L. Lichtenstein, N. Malet, and B. Perret Chronic pharmacological activation of P2Y(13) receptor in mice decreases HDL-cholesterol level by increasing hepatic HDL uptake and bile acid secretion Biochim Biophys Acta 1831 2012 719 725
24. W.H. Sheu, A.L. Swislocki, B. Hoffman, Y.D. Chen, and G.M. Reaven Comparison of the effects of atenolol and nifedipine on glucose, insulin, and lipid metabolism in patients with hypertension Am J Hypertens 4 1991 199 205
25. B.M. Singh, and J.L. Mehta Interactions between the renin-angiotensin system and dyslipidemia: relevance in the therapy of hypertension and coronary heart disease Arch Intern Med 163 2003 1296 1304
26. M. Tonooka, I. Kawashima, M. Sakashita, H. Yasuhara, and K. Sakamoto Effect of chronic treatment of propranolol on lipid metabolism in spontaneously hypertensive rats (SHR) Jpn J Pharmacol 37 1985 335 344
27. N. Ueno, and Y. Satou The enhanced effect of atenolol on hypertension in metabolic syndrome Metab Syndr Relat Disord 9 2011 369 373
28. A.N. Wadworth, D. Murdoch, R.N. Brogden, and Atenolol A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders Drugs 42 1991 468 510
29. Y. Xu, Q. Bao, B. He, Y. Pan, R. Zhang, and X. Mao Association of angiotensin I converting enzyme, angiotensin II type 1 receptor and angiotensin I converting enzyme 2 gene polymorphisms with the dyslipidemia in type 2 diabetic patients of Chinese Han origin J Endocrinol Invest 35 2012 378 383